Filing Details

Accession Number:
0001317757-10-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-01 13:00:00
Reporting Period:
2010-05-28
Filing Date:
2010-06-01
Accepted Time:
2010-06-01 16:19:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
792977 Amag Pharmaceuticals Inc. AMAG In Vitro & In Vivo Diagnostic Substances (2835) 042742593
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408474 Phd Md F Lee Allen C/O Amag Pharmaceuticals, Inc.
100 Hayden Avenue
Lexington MA 02421
Chief Medical Officer And Evp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-28 626 $27.06 4,412 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares were acquired by the reporting person pursuant to the Company's 2010 Employee Stock Purchase Plan. The purchase price for the shares was 85% of the closing price of the Company's common stock on May 28, 2010.